NFKB1 and hepatocellular carcinoma: Previous studies have shown that TLR4/MyD88/NF-κB pathway is linked to the inflammatory response in hepatocellular carcinoma [34], breast cancer [35], and tumor-associated macrophages (TAMs) on Ishikawa cells [36].